USPTO serial 79299178
FEMCHECK
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 2, 2021
- Examiner
- CAYSIDO, REBECCA TOLENTINO
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with FEMCHECK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Palmerston North, NZ
Palmerston North, NZ
Palmerston North, NZ
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; chemical diagnostic reagents and assays for medical purposes for use in diagnostic in vitro test kits for home use in the field of fertility monitoring, namely medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to track ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females | ACTIVE | — |
| 009 | Downloadable software and downloadable mobile applications for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring in particular with kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; Downloadable software and downloadable mobile applications for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females | ACTIVE | — |
| 035 | Retail and wholesale store services for non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for chemical diagnostic reagents and assays for medical purposes for use in diagnostic in vitro test kits for home use in the field of fertility monitoring, namely medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to track ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for downloadable software and downloadable mobile applications for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for downloadable software and downloadable mobile applications for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for software as a service (SAAS) services featuring software for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring, namely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for software as a service (SAAS) services for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; online advertising and marketing services in relation to the aforementioned goods | ACTIVE | — |
| 042 | Software as a service (SAAS) services featuring software for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring in particular with kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; software as a service (SAAS) services featuring software for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; providing temporary use of online non-downloadable computer software for use with non-prescription, over the counter, diagnostic in vitro test kits for home use in the field of fertility monitoring in particular with kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, and to quantitate urinary based assays to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females; providing temporary use of online non-downloadable computer software for testing and tracking urinary metabolites, in particular estrogen metabolites, progesterone metabolites, cortisol metabolites and testosterone metabolites, to monitor ovulation and ovarian activity, to identify ovulation dates and to identify fertility periods of females | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SCIENCE HAVEN LIMITED
- Other trademarks owned by SCIENCE HAVEN LIMITED
- Other trademarks owned by SCIENCE HAVEN LIMITED
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named FEMCHECK
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 16, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 22, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 22, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 2, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 2, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 17, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 17, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 15, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 28, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 28, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 28, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 13, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 13, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 13, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 13, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 13, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 17, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 16, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 16, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 23, 2021 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Mar 23, 2021 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Feb 28, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Feb 26, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 11, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 16, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 16, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 8, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 8, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 7, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 4, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 4, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 3, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |